Agomelatine, a melatonin agonist with antidepressant properties. - Wikidata - awgldk - TriplyDB

Agomelatine, a melatonin agonist with antidepressant properties.

Agomelatine, a melatonin agonist with antidepressant properties.

http://www.wikidata.org/entity/Q37598264

about

Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.Markers of Oxidative Stress and Neuroprogression in Depression Disorder.Exacerbated mechanical hyperalgesia in rats with genetically predisposed depressive behavior: role of melatonin and NMDA receptors.Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects.Insomnia and dementia: is agomelatine treatment helpful? Case report and review of the literature.Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes Genetic variants in MTNR1B affecting insulin secretion.Cardiovascular effects of melatonin receptor agonists.Current Phase II investigational therapies for insomnia.Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients.A chronobiological approach to addiction

P2860

Q26772851-26A0D0F5-A8AB-4616-90FD-4154C2ABB315 Q34358480-A807FE88-6A10-4064-B332-7658788D77EC Q35677056-5F71A500-4A68-45E8-A536-8C471F1A7047 Q36389131-61676007-68FF-43CB-9944-559ED7C5CB69 Q36495583-B03BF2F5-EC2E-4147-8F73-E323B49FFF05 Q37148272-50F13D5F-9915-4FE8-BF89-43591B327A4A Q37173576-98A71D60-F77D-4C88-AECE-17F6B9D3E329 Q37769561-21131094-EA41-454B-A72D-A15FA5FAD0E5 Q38037124-FA4DC649-9714-492A-B7D1-6A31F29D8DFD Q38271292-B5E0E680-8C47-4623-A823-2CE73E786D1B Q53634760-43791B51-9187-4EBF-96C3-7C5E22E2282A Q58917927-1B59FEFA-A931-4835-8AAC-A2ADCC0FA31C

P2860

Agomelatine, a melatonin agonist with antidepressant properties.

http://www.wikidata.org/entity/Q37598264

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Agomelatine, a melatonin agonist with antidepressant properties.

@en

Agomelatine, a melatonin agonist with antidepressant properties.

@nl

type

label

Agomelatine, a melatonin agonist with antidepressant properties.

@en

Agomelatine, a melatonin agonist with antidepressant properties.

@nl

prefLabel

Agomelatine, a melatonin agonist with antidepressant properties.

@en

Agomelatine, a melatonin agonist with antidepressant properties.

@nl

P1433

Q37598264-8D5791FF-332B-497D-B098-619FC5721315

P1476

Q37598264-1A8F1319-23BB-4B3B-868F-85EE2C941906

P2093

Q37598264-A67FC746-5F82-4C45-BAD9-1109B45EC958

Q37598264-F8124E3D-D5EA-4D44-8209-3B11B0A96E55

P2860

Q37598264-1E1034DF-C37B-4AA8-B1C2-301B528E0839

Q37598264-23D4E735-BBBC-454D-9C81-8667897E8656

Q37598264-2665548D-EDDE-48DF-A9F9-61D22ADD96CB

Q37598264-2C8559AB-9EAA-468A-BBDC-CD6F18281064

Q37598264-3278FAE5-08C2-42F5-8940-42E9B9EBEC42

Q37598264-337AC369-DD75-42FB-B276-25BAD9E5038A

Q37598264-3AD21BFE-90C1-47DF-8F16-9D06E5908A13

Q37598264-452F9009-0789-4BC2-A8EC-3D1397F5AB1F

Q37598264-521368E7-6071-45F8-9F18-74D99A569CD7

Q37598264-56F45C23-EEB3-4FA6-ADD6-860D3C3EDD55

P304

Q37598264-7DD034BD-C50F-4020-BCF5-E4E58C3FE3B1

P31

Q37598264-E14F26E9-C84E-4DF2-B49A-BBEFD20D670F

P356

Q37598264-3096628E-0FBE-4779-B501-EF79AFE6E0BF

P407

Q37598264-C506EA71-1FA4-4073-8825-95D337159A44

P433

Q37598264-61ADDB9D-5987-4357-A4E3-1541F6D50949

P478

Q37598264-9BC06DCC-C03A-4E85-BD9E-C2103A67D0FD

P577

Q37598264-BDC0E215-6B50-4B22-8AC8-A8681E85B505

P698

Q37598264-97164F55-BA48-47D7-97D1-E3A093DE0EA8

P921

Q37598264-71E5CDA1-8B9F-45C1-98F7-42CE17DACE96

P356

13543780903292634

P1433

Expert Opinion on Investigational Drugs

P1476

Agomelatine, a melatonin agonist with antidepressant properties.

@en

P2093

Calvert Warren

http://www.w3.org/2001/XMLSchema#string

Steven L Dubovsky

http://www.w3.org/2001/XMLSchema#string

P2860

The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways

Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine

Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data

Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine

Agomelatine in the treatment of seasonal affective disorder

Network pharmacology: the next paradigm in drug discovery

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

Intracoronary ketanserin augments coronary collateral blood flow and decreases myocardial ischemia during balloon angioplasty.

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthre

P304

1533-1540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543780903292634

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19758108

http://www.w3.org/2001/XMLSchema#string

P921